"Inflammatory Bowel Disease - Advances in Pathogenesis and Management" ed. by Sami Karoui

This book is dedicated to inflammatory bowel disease, and the authors discuss the advances in the pathogenesis of inflammatory bowel disease, as well as several new parameters involved in the etiopathogeny of Crohn's disease and ulcerative colitis, such as intestinal barrier dysfunction and the roles of TH 17 cells and IL 17 in the immune response in inflammatory bowel disease.

The book also focuses on several relevant clinical points, such as pregnancy during inflammatory bowel disease and the health-related quality of life as an end point of the different treatments of the diseases. Finally, advances in management of patients with inflammatory bowel disease are discussed, especially in a complete review of the recent literature.

Contents
Preface
Part 1 Pathogenesis of Inflammatory Bowel Disease
1 The Role of COX-2 Inhibitors on Experimental Colitis
2 Intestinal Barrier Dysfunction: The Primary Driver of IBD?
3 Adenosine Receptors: New Targets to Protect Against Tissue Damage in Inflammatory Bowel Symptoms
4 Role of Dipeptidyl Peptidase IV/CD26 in Inflammatory Bowel Disease
5 The Roles of Interleukin-17 and T Helper 17 Cells in Intestinal Barrier Function
6 Pathogenesis of Inflammatory Bowel Diseases
Part 2 Advances in Diagnosis of Inflammatory Bowel Disease
7 The Role of Imaging in Inflammatory Bowel Disease Evaluation
8 Health-Related Quality of Life in Inflammatory Bowel Disease
9 Validation of a Quantitative Determination Method of Paramino-Salicylic Acid by High-Performance Liquid Chromatography and Its Application in Rat Plasma
10 Approach to the Management of the Pregnant Inflammatory Bowel Disease Patient: Successful Outcome
11 Bone Morphogenetic Proteins and Signaling Pathway in Inflammatory Bowel Disease
12 Genetic Differentiation of Fungi of the Genus Candida Isolated from Patients with Inflammatory Bowel Diseases
13 A 9-Year Retrospective Study of Hospitalized IBD Patients in Shanghai Rui Jin Hospital
Part 3 Management of Inflammatory Bowel Disease
14 The Role of Diet, Prebiotic and Probiotic in the Development and Management of Inflammatory Bowel Diseases (IBD)
15 The Use of Pomegranate (Punica granatum L.) Phenolic Compounds as Potential Natural Prevention Against IBDs
16 Drug Targeting in IBD Treatment - Existing and New Approaches